SCYNEXIS Inc (SCYX)
1.565
-0.06
(-3.99%)
USD |
NASDAQ |
Sep 20, 16:00
1.56
0.00 (0.00%)
After-Hours: 20:00
SCYNEXIS Cash from Investing (Quarterly): 1.372M for June 30, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 1.372M |
| March 31, 2024 | 5.454M |
| December 31, 2023 | -2.152M |
| September 30, 2023 | -26.34M |
| June 30, 2023 | -6.384M |
| March 31, 2023 | 0.00 |
| December 31, 2022 | 0.00 |
| September 30, 2022 | -27.38M |
| June 30, 2022 | 0.00 |
| March 31, 2022 | -0.009M |
| December 31, 2021 | -0.583M |
| September 30, 2021 | -0.338M |
| June 30, 2021 | -0.051M |
| March 31, 2021 | -0.20M |
| December 31, 2020 | 0.00 |
| September 30, 2020 | 3.571M |
| June 30, 2020 | 10.66M |
| March 31, 2020 | -7.762M |
| December 31, 2019 | 10.04M |
| September 30, 2019 | -0.421M |
| June 30, 2019 | 10.02M |
| March 31, 2019 | 6.597M |
| December 31, 2018 | 0.595M |
| Date | Value |
|---|---|
| September 30, 2018 | 14.94M |
| June 30, 2018 | -12.33M |
| March 31, 2018 | -4.005M |
| December 31, 2017 | 6.563M |
| September 30, 2017 | 2.944M |
| June 30, 2017 | -6.964M |
| March 31, 2017 | -12.16M |
| December 31, 2016 | 5.626M |
| September 30, 2016 | -15.61M |
| June 30, 2016 | -12.47M |
| March 31, 2016 | -0.014M |
| December 31, 2015 | -0.416M |
| September 30, 2015 | 2.529M |
| June 30, 2015 | -0.356M |
| March 31, 2015 | -0.171M |
| December 31, 2014 | -0.072M |
| September 30, 2014 | -0.309M |
| June 30, 2014 | -0.033M |
| March 31, 2014 | -0.074M |
| December 31, 2013 | -0.061M |
| September 30, 2013 | -0.055M |
| June 30, 2013 | 0.425M |
| March 31, 2013 | 0.248M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-27.38M
Minimum
Sep 2022
10.66M
Maximum
Jun 2020
-2.026M
Average
-0.03M
Median
Cash from Investing (Quarterly) Benchmarks
| Inogen Inc | -12.38M |
| NovaBay Pharmaceuticals Inc | -0.002M |
| Palatin Technologies Inc | 0.00 |
| iBio Inc | 1.00M |
| Theriva Biologics Inc | -0.001M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -10.86M |
| Free Cash Flow | -10.18M |
| Free Cash Flow Per Share (Quarterly) | -0.2239 |
| Free Cash Flow to Equity (Quarterly) | -23.64M |
| Free Cash Flow to Firm (Quarterly) | -10.86M |
| Free Cash Flow Yield | -13.49% |